Statements (32)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:chemical_compound
antiprotozoal drug |
gptkbp:ATCCode |
P01AA03
|
gptkbp:CASNumber |
83-73-8
|
gptkbp:chemicalFormula |
C9H6I2N2O
|
gptkbp:contraindication |
optic neuritis
hypersensitivity to iodine |
gptkbp:discoveredBy |
gptkb:Bayer
|
gptkbp:discoveredIn |
1936
|
https://www.w3.org/2000/01/rdf-schema#label |
iodoquinol
|
gptkbp:KEGGID |
D00341
|
gptkbp:legalStatus |
prescription only
|
gptkbp:mechanismOfAction |
unknown
|
gptkbp:MedlinePlusID |
a682437
|
gptkbp:meltingPoint |
205–210 °C
|
gptkbp:molecularWeight |
396.97 g/mol
|
gptkbp:otherName |
8-hydroxy-5,7-diiodoquinoline
diiodohydroxyquinoline |
gptkbp:pregnancyCategory |
C (US)
|
gptkbp:PubChem_CID |
CHEMBL1201272
657298 DB01125 |
gptkbp:routeOfAdministration |
oral
|
gptkbp:sideEffect |
nausea
vomiting diarrhea abdominal cramps |
gptkbp:solubility |
practically insoluble in water
|
gptkbp:UNII |
6TZ7XAZ1EA
|
gptkbp:usedFor |
treatment of amoebiasis
|
gptkbp:bfsParent |
gptkb:Entamoeba_histolytica
|
gptkbp:bfsLayer |
8
|